← Scroll for more →
Financial Statements — RHLD
Balance Sheet
(in billions USD)| Metric | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 0.12 | 0.11 | 0.10 | 0.10 | 0.07 |
| Total Current Assets | 0.82 | 0.94 | 0.26 | 0.22 | 0.18 |
| Total Assets | 6.13 | 6.22 | 0.29 | 0.25 | 0.21 |
| Total Current Liabilities | 0.61 | 0.59 | 0.07 | 0.06 | 0.05 |
| Long-term Debt | 2.18 | 2.18 | 0.17 | 0.18 | 0.18 |
| Total Liabilities | 3.07 | 3.13 | 0.25 | 0.25 | 0.24 |
| Retained Earnings | 0.04 | 0.05 | (0.01) | (0.01) | (0.01) |
| Total Stockholder Equity | (0.03) | 0.03 | 0.01 | 0.01 | 0.01 |
← Scroll for more columns →
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Pretax Income | 97.50 | (142.40) | 33.66 | 39.47 | 38.60 | 23.18 |
| Tax Provision | 42.80 | (49.80) | (0.04) | 0.06 | 0.30 | 0.57 |
| Net Income | (12.40) | 61.50 | (1.71) | (0.23) | (0.61) | (3.37) |
| Basic EPS | (1.53) | 7.27 | (0.20) | (0.03) | (0.07) | (0.39) |
| Diluted EPS | (1.53) | 7.19 | (0.20) | (0.03) | (0.07) | (0.39) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 93.60 | (116.80) | 69.21 | 59.59 | 48.92 | 18.37 |
| Capital Expenditures | 12.30 | 7.40 | 3.91 | 0.98 | 1.40 | 0.58 |
| Free Cash Flow* | 81.30 | (124.20) | 65.30 | 58.62 | 47.52 | 17.79 |
| Investing Cash Flow | (15.40) | (632.60) | 1.82 | (50.41) | (1.64) | (1.16) |
| Financing Cash Flow | (88.00) | 711.00 | (7.91) | (10.80) | (18.43) | (17.78) |
← Scroll for more columns →
* Derived from reported values